Hribernik, N., Strašek, K., Studen, A., Zevnik, K., Škalič, K., Jeraj, R., & Reberšek, M. (2025). Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy. Radiology and Oncology, 59(1), 43–53. Retrieved from https://www.radioloncol.com/index.php/ro/article/view/4548